Titlebook: Regulation Under Increasing Competition; Michael A. Crew Book 1999 Springer Science+Business Media New York 1999 Change.Monopol.competitio

凹室

Introduction,ch by several laboratories to develop receptor subtype-specific NMDA antagonists in order to avoid the wide range of side-effects seen with non-selective NMDA ion channel antagonists such as ketamine.